ArticleAnnals of medicine2026
Early detection of severe fetal growth restriction using multimodal deep learning based on ultrasound and prenatal biomarkers.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop and evaluate a multimodal deep learning model that integrates first- and second-trimester ultrasound images with first-trimester maternal serum biomarkers for early prediction of severe fetal growth restriction (FGR). MATERIALS AND
methodsIn this prospective study, 13,991 pregnant women were initially recruited, and after applying inclusion and exclusion criteria, 598 singleton pregnancies (299 with severe FGR and 299 controls) were analyzed. Severe FGR was diagnosed at or after 24 weeks' gestation and defined as an estimated fetal weight (EFW) or abdominal circumference (AC) below the 3rd percentile. Seven ultrasound views were collected (first-trimester crown-rump length, nuchal translucency; second-trimester head and abdominal circumference, femur length, umbilical artery S/D ratio, and amniotic fluid depth), along with maternal age and first-trimester serum markers (PAPP-A and free β-hCG, expressed as MoM). A convolutional neural network (CNN) with multi-level attention and dynamic convolution modules was trained end-to-end using stochastic gradient descent with cross-entropy loss. Model performance was evaluated with five-fold cross-validation.
resultsThe integrated model achieved high predictive accuracy for severe FGR, with an AUC of approximately 0.96, accuracy of 91%, and F1-score of 0.912. Matthews correlation coefficient (MCC) was 0.798. The model outperformed single-modality baselines, such as a ResNet-50 CNN trained on images alone. Ablation experiments showed that adding maternal serum biomarkers and advanced CNN modules significantly improved performance. The model demonstrated excellent discrimination between severe FGR and control cases, with high sensitivity and precision in classification.
conclusionsA deep learning model combining routine ultrasound and first-trimester serum biomarkers can accurately predict severe FGR before clinical signs appear. This model significantly enhances early severe FGR risk stratification and suggests potential for AI-based prediction tools in prenatal care to guide earlier surveillance and intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.